저니 메디컬 (DERM) 주가

저니 메디컬(DERM)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $7.31 (-0.68%), 시가총액 $0.17B, 52주 최저~최고 $4.39 ~ $9.26.

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammat

핵심 지표

• 현재가: $7.31 (-0.68%)
• 시가총액: $0.17B
• 52주 최저~최고: $4.39 ~ $9.26
• 섹터: Healthcare
• 산업: Drug Manufacturers - Specialty & Generic
• 거래소: NASDAQ

저니 메디컬의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

저니 메디컬 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.75

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 5.51
• 순이익률: -0.15%
• 영업이익률: -0.09%

자주 묻는 질문